GNTA — Genenta Science SpA Cashflow Statement
0.000.00%
Last trade - 00:00- $112.94m
- $92.83m
- 32
- 18
- 26
- 15
Annual cashflow statement for Genenta Science SpA, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 20-F | 20-F | 20-F |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -4.6 | -5.59 | -5.53 | -8.48 | -11.6 |
| Depreciation | |||||
| Non-Cash Items | 0.754 | 0.466 | 0.51 | 0.813 | 0.816 |
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.35 | -0.921 | -1.94 | 0.24 | -0.418 |
| Change in Prepaid Expenses | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Cash from Operating Activities | -2.49 | -6.04 | -6.96 | -7.42 | -11.2 |
| Capital Expenditures | 0 | -0.021 | -0.009 | -0.027 | -0.014 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | — | — | — | — | -14.9 |
| Purchase of Investments | |||||
| Cash from Investing Activities | 0 | -0.021 | -0.009 | -0.027 | -14.9 |
| Financing Cash Flow Items | -0.319 | -0.111 | 0 | 0 | 0.001 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Cash from Financing Activities | 14.8 | 1.39 | 28.7 | 0 | 0.001 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 12.3 | -4.68 | 21.8 | -7.45 | -26.1 |